BAGNEUX, France, Genomic Vision (FR0011799907 – GV, the "Company"), a Euronext-listed biotechnology company that develops products and services for the highly accurate characterization of transformed cells, announces having filed today a declaration of cessation of payments ("déclaration de cessation des paiements") with the Commercial Court of Nanterre. The employee representative bodies were informed on October [...]

Consortium Aims to Share Best Practices and Increase our Understanding of Genetic Disease MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the creation of the HiFi Solves consortium. This global consortium brings together researchers from 15 leading genomics research institutions across 11 countries to study the value HiFi-based [...]

Partnership combines QIAGEN’s QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element’s AVITI System users in genomic analysis Collaboration to accelerate discovery, enhance cost efficiencies, and improve turnaround times for genomic applications in the scientific community QIAGEN to present performance data for universal QIAseq library preparation panels running on other sequencing platforms at [...]

Company has signed virtual power purchase agreements (VPPAs) for a total of around 300 gigawatt hours (GWh) of renewable energy per year. Company signs virtual power purchase agreements for 300 gigawatt hours per year Wind and solar farms operational in Spain from 2025 Important milestone for strategic sustainability goal of Merck KGaA, Darmstadt, Germany, to [...]

DKSH has signed an agreement to acquire Bio-Strategy Limited (“Bio-Strategy”), the largest independent distributor of scientific instruments in Australia and New Zealand. With this acquisition, DKSH grows its Scientific Instrumentation business in line with Business Unit Technology’s strategy to build resilience and deliver profitable growth. Zurich, Switzerland – DKSH has announced today that it signed [...]

SAN DIEGO -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that optical genome mapping (OGM) was included for the first time in Thompson and Thompson Genetics and Genomics in Medicine, 9th edition, a textbook regularly used for medical students, genetic counseling students, students in laboratory medicine, and more advanced trainees pursuing American Board of Medical Genetics and [...]

Life Sciences Pioneer Todd Dickinson, Ph.D., Appointed as CEO; Spatial Biology Innovator Ye Fu, PhD., Appointed as CTO Boston – Stellaromics, a leading provider of in situ spatial multi-omics technology, today announced that the company has raised $25 million in a Series A financing round. The Series A financing round included Plaisance Capital Management and [...]

SAN JOSE & NEW YORK – Complete Genomics and Basepair, Inc today announced a technology integration partnership to accelerate the analysis and interpretation of genomic data generated by Complete Genomics’ DNBSEQ™ sequencing platforms. The partnership gives Complete Genomics’ customers seamless access to Basepair’s bioinformatics platform deployed on Amazon Web Services (AWS) and use its easy-to-use [...]

Centralized hub for advanced testing of nucleic acids to simplify mRNA drug substance testing, accelerating critical therapeutic development SAN DIEGO –TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has launched its Analytical Sciences Center of Excellence (ASCE) hub. Expanding its comprehensive suite of analytical testing capabilities, this [...]

WATERTOWN, Mass. — Fluent BioSciences, a cutting-edge life science company transforming single cell analysis through simple, cost-effective, and highly scalable single-cell RNA sequencing solutions, is excited to announce a partnership with Singular Genomics, a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians. Together, they unveil the compatibility of PIPseq™ [...]